CD8+ T cells in ccRCC patients display defective anti-apoptotic and proliferative capacity due to miR-29b/miR-198-mediated suppression of JAK3 and MCL-1—a dysfunction reversible via miRNA inhibition [119]. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.